EXTERNALIZED IMMUNE SYSTEM
Live / Registered — Registered (as of 06 Oct 2026)
What this means for you
Registered since 06 Oct 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 06 Oct 2032: the §8 declaration of use).
Record
- Serial number
- 97709699
- Registration number
- 8486986
- Mark type
- Word mark
- Filed
- 08 Dec 2022
- Published for opposition
- 14 Nov 2023
- Registered
- 06 Oct 2026
- Next maintenance filing
- §8 declaration of use, due by 06 Oct 2032 (grace period to 06 Apr 2033)
- Attorney of record
- Jeffrey R. Kurin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biologic preparations for use in oncology, immunology, and cell degeneration; Pharmaceutical preparations, namely, therapeutic agents, immunotherapies, antibody therapies, and cell therapies for the treatment of cancer, autoimmune diseases and disorders, degenerative diseases and disorders; Antibodies for medical and medical diagnostic laboratory use
Owner
- Prellis Biologics, Inc., Berkeley, CA, US
- Prellis Biologics, Inc., Berkeley, CA, US
- Prellis Biologics, Inc., Hayward, CA, US
Prosecution history
- 06 Oct 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Oct 2026 — REGISTERED-PRINCIPAL REGISTER
- 16 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Aug 2026 — USE AMENDMENT FILED
- 24 Aug 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Aug 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Aug 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 24 Aug 2026 — TEAS STATEMENT OF USE RECEIVED
- 23 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Aug 2026 — SOU EXTENSION 5 GRANTED
- 06 Jul 2026 — SOU EXTENSION 5 FILED
- 22 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Jul 2026 — SOU TEAS EXTENSION RECEIVED